Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hagedoorn

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
International Journal of Pharmaceutics|December 4, 2003
The choice of a compressor for the aerosolisation of tobramycin (TOBI) with the PARI LC PLUS reusable nebuliserA H de Boer, P Hagedoorn, H W Frijlink
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 6, 2013
Developments and strategies for inhaled antibiotic drugs in tuberculosis therapy: a critical evaluationM Hoppentocht, P Hagedoorn, H W Frijlink, et al.
International Journal of Pharmaceutics|November 16, 2002
Characterization of inhalation aerosols: a critical evaluation of cascade impactor analysis and laser diffraction techniqueA H de Boer, D Gjaltema, P Hagedoorn, et al.
Die Pharmazie|October 23, 2004
Comparative in vitro performance evaluation of the Novopulmon 200 Novolizer and Budesonid-ratiopharm Jethaler: two novel budesonide dry powder inhalersA H de Boer, D Gjaltema, P Hagedoorn, et al.
Advanced Drug Delivery Reviews|April 17, 2014
Technological and practical challenges of dry powder inhalers and formulationsM Hoppentocht, P Hagedoorn, H W Frijlink, et al.
International Journal of Pharmaceutics|July 5, 2003
Air classifier technology (ACT) in dry powder inhalation. Part 1. Introduction of a novel force distribution concept (FDC) explaining the performance of a basic air classifier on adhesive mixturesA H de Boer, P Hagedoorn, D Gjaltema, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 5, 2014
In vitro evaluation of the DP-4M PennCentury insufflatorM Hoppentocht, C Hoste, P Hagedoorn, et al.
International Journal of Pharmaceutics|January 31, 2006
Air classifier technology (ACT) in dry powder inhalation Part 3. Design and development of an air classifier family for the Novolizer multi-dose dry powder inhalerA H de Boer, P Hagedoorn, D Gjaltema, et al.
International Journal of Pharmaceutics|January 31, 2006
Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhalerA H de Boer, P Hagedoorn, D Gjaltema, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|January 24, 2015
The Cyclops for pulmonary delivery of aminoglycosides; a new member of the Twincer™ familyM Hoppentocht, O W Akkerman, P Hagedoorn, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
International Journal of Pharmaceutics|December 4, 2003
The choice of a compressor for the aerosolisation of tobramycin (TOBI) with the PARI LC PLUS reusable nebuliserA H de Boer, P Hagedoorn, H W Frijlink
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 6, 2013
Developments and strategies for inhaled antibiotic drugs in tuberculosis therapy: a critical evaluationM Hoppentocht, P Hagedoorn, H W Frijlink, et al.
International Journal of Pharmaceutics|November 16, 2002
Characterization of inhalation aerosols: a critical evaluation of cascade impactor analysis and laser diffraction techniqueA H de Boer, D Gjaltema, P Hagedoorn, et al.
Die Pharmazie|October 23, 2004
Comparative in vitro performance evaluation of the Novopulmon 200 Novolizer and Budesonid-ratiopharm Jethaler: two novel budesonide dry powder inhalersA H de Boer, D Gjaltema, P Hagedoorn, et al.
Advanced Drug Delivery Reviews|April 17, 2014
Technological and practical challenges of dry powder inhalers and formulationsM Hoppentocht, P Hagedoorn, H W Frijlink, et al.
International Journal of Pharmaceutics|July 5, 2003
Air classifier technology (ACT) in dry powder inhalation. Part 1. Introduction of a novel force distribution concept (FDC) explaining the performance of a basic air classifier on adhesive mixturesA H de Boer, P Hagedoorn, D Gjaltema, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 5, 2014
In vitro evaluation of the DP-4M PennCentury insufflatorM Hoppentocht, C Hoste, P Hagedoorn, et al.
International Journal of Pharmaceutics|January 31, 2006
Air classifier technology (ACT) in dry powder inhalation Part 3. Design and development of an air classifier family for the Novolizer multi-dose dry powder inhalerA H de Boer, P Hagedoorn, D Gjaltema, et al.
International Journal of Pharmaceutics|January 31, 2006
Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhalerA H de Boer, P Hagedoorn, D Gjaltema, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|January 24, 2015
The Cyclops for pulmonary delivery of aminoglycosides; a new member of the Twincer™ familyM Hoppentocht, O W Akkerman, P Hagedoorn, et al.
Pageof 3